# Evaluation Summary

## Metrics

| Condition | Exact agreement | N | k | Backend |
|---|---:|---:|---:|---|
| No-RAG | 33.3% | 30 | 5 | anthropic |

## Inferential (Paired t-test)

- Mean agreement delta (RAG - No-RAG): 0.00 points
- Improved / worse / unchanged: 0 / 0 / 30
- t-statistic: 0.0
- p-value: 1
- df: 29

## Parameters

- Dataset: data/test_cases_v2.csv
- Seed: 42
- Model: claude-haiku-4-5-20251001
- Embedding model: BAAI/bge-small-en-v1.5
- Retrieval mode: embeddings
- Git commit: 010a0da91de9c2c0bc75028390f054050b91c465

## Example Cases (5–10)

- gen-019: gold=NONE | no-rag=NONE | rag=NONE
- gen-020: gold=NONE | no-rag=NONE | rag=NONE
- gen-021: gold=NONE | no-rag=NONE | rag=NONE
- gen-022: gold=NONE | no-rag=NONE | rag=NONE
- gen-001: gold=http://purl.bioontology.org/ontology/AIR/DXRA | no-rag=NONE | rag=NONE
- gen-002: gold=http://purl.bioontology.org/ontology/AIR/DXRA | no-rag=NONE | rag=NONE
- gen-003: gold=http://purl.bioontology.org/ontology/AIR/DXRA | no-rag=NONE | rag=NONE
- gen-004: gold=http://purl.bioontology.org/ontology/AIR/DXSLE | no-rag=NONE | rag=NONE

## Differential Diagnosis Snippets (RAG)

- gen-001: # DIFFERENTIAL DIAGNOSIS ANALYSIS

## PRIMARY DIAGNOSIS: Rheumatoid Arthritis (RA)
**Confidence: High**

**Supporting findings:**
- Symmetric polyarticular involvement of MCP and PIP joints (2nd-5th digits bilaterally) with morning stiffness lasting 90 minutes—classic for RA
- Positive RF (78 IU/mL, markedly elevated) and anti-CCP (156 units/mL, strongly positive)—anti-CCP is highly specific for RA and predictive of erosive disease
- Elevated inflammatory markers (ESR 48, CRP 23) with clinical synovitis (warm, tender swollen joints) consistent with active inflammatory disease; mild normocytic anemia is typical in chronic RA

**Findings against:**
- None identified. Absence of erosions on baseline imaging is expected early in disease; anti-CCP positivity predicts their future development.

---

## DIFFERENTIAL DIAGNOSIS:

1. **Lyme Arthritis (Early Disseminated Lyme Disease)** (8%) 
   — *for:* Symmetric polyarticular arthritis, morning stiffness, elevated inflammatory markers | *against:* Patient explicitly denies tick exposure/travel; RF and anti-CCP strongly positive (Lyme arthritis is typically RF/anti-CCP negative or low-titer); Lyme arthritis typically more monoarticular or oligoarticular

2. **Polymyalgia Rheumatica (PMR)** (5%) 
   — *for:* Age-appropriate (52 at lower end but possible), morning stiffness, elevated ESR/CRP | *against:* PMR classically presents with proximal shoulder/hip girdle aching, NOT small joint polyarthritis; no mention of shoulder/hip pain; RF and anti-CCP positive (atypical for PMR)

3. **Early Systemic Lupus Erythematosus (SLE)** (3%) 
   — *for:* Symmetric polyarthritis, morning stiffness, female predominance, mild anemia | *against:* ANA negative (highly sensitive for SLE; negative ANA essentially excludes SLE); absence of constitutional symptoms (fever, weight loss, rashes, oral ulcers)

---

## REASONING:

This case presents a textbook picture of early seropositive rheumatoid arthritis. The critical discriminating findings are the **dual positivity for RF and especially anti-CCP**, which together achieve >95% specificity for RA and predict erosive progression. The **symmetric small-joint polyarthritis** affecting MCPs and PIPs with **prolonged morning stiffness (90 minutes)** is the archetypal presentation. The elevated acute phase reactants (ESR 48, CRP 23) with objective synovitis on exam confirm active inflammation. While other conditions (Lyme, PMR, SLE) could theoretically present with polyarthritis, each is effectively excluded: Lyme arthritis presents without seropositivity and with clear epidemiologic risk factors; PMR presents with proximal girdle symptoms and low serology; SLE is ruled out by negative ANA. The absence of erosions does not argue against RA in this early 8-week timeframe—anti-CCP positivity is actually a harbinger of future erosive disease and justifies aggressive DMARD initiation.

---

## NEXT STEP:

**Obtain high-resolution ultrasound or MRI of hands and wrists to assess for synovitis and early erosions/bone edema.** 

*Expected finding:* Ultrasound will likely demonstrate power Doppler signal in synovial tissue and MRI may show bone marrow edema at MCP/PIP joints and wrist, confirming active synovitis and providing baseline documentation of inflammatory burden. This would strengthen the RA diagnosis and may identify subclinical bone damage not visible on plain films, guiding intensity of DMARD therapy. Additionally, consider HLA-B27 testing only if clinical suspicion for spondyloarthropathy emerges (which is currently low).
- gen-002: # RHEUMATOLOGIC DIFFERENTIAL DIAGNOSIS

**PRIMARY DIAGNOSIS: Rheumatoid Arthritis (Seropositive)**

**Confidence:** High

**Supporting findings:**
- Bilateral symmetric PIP joint involvement (digits 2-4), the classic distribution for RA
- Positive RF (42 IU/mL) and anti-CCP (78 units/mL), both highly specific for RA with anti-CCP being more specific
- Elevated inflammatory markers (ESR 18, CRP 4.2) despite relatively mild clinical presentation, consistent with early/mild RA

**Findings against:**
- Absence of prolonged morning stiffness (only 20 minutes), which is typical but not required for RA diagnosis
- No erythema or warmth on examination, though this does not exclude RA, particularly in early disease

---

## DIFFERENTIAL DIAGNOSIS:

1. **Psoriatic Arthritis (PsA)** (15%) — for: insidious onset, PIP involvement, intermittent course | against: no skin/nail findings, negative ANA pattern inconsistent with typical PsA, DIP joints not involved

2. **Osteoarthritis (OA)** (8%) — for: age 52, PIP predominance, female gender | against: bilateral symmetric presentation, positive serologies (RF/anti-CCP) highly atypical for OA, elevated inflammatory markers, occupation-related explanation incomplete

3. **Systemic Lupus Erythematosus (SLE)** (5%) — for: female, hand arthritis, elevated inflammatory markers | against: negative ANA essentially excludes SLE, no photosensitivity or systemic symptoms, anti-CCP positivity argues strongly against SLE

---

## REASONING:

This case presents a compelling picture of **seropositive RA** with relatively mild disease activity. The combination of bilateral symmetric PIP polyarthritis with dual seropositivity (RF and anti-CCP) is pathognomonic for RA; anti-CCP positivity in particular predicts erosive, progressive disease. While the patient lacks prolonged morning stiffness and has good functional capacity, these do not exclude RA—approximately 30% of RA patients have <30 minutes of morning stiffness, and early/mild disease may present with intermittent symptoms. The temporal pattern of "coming and going" over 8 months fits early RA before disease becomes established and continuous. The negative ANA effectively excludes lupus-mediated arthritis. Psoriatic arthritis is unlikely without cutaneous/ungual findings and would more typically involve DIP joints or show asymmetry. The reduced grip strength (28 vs 35 kg predicted) reflects true joint dysfunction rather than occupational strain alone.

---

## NEXT STEP:

**Hand/wrist X-rays (posteroanterior views with proper positioning)**

**Expected finding:** Currently normal or showing only soft tissue swelling, which would support early seropositive RA before erosive changes develop. If erosions are already present on PIP or MCP joints, this confirms established RA with prognostic implications for aggressive disease. The absence of erosions at this stage would still be entirely consistent with early RA but would support urgent initiation of disease-modifying antirheumatic therapy (DMARDs) to prevent irreversible damage, given the dual seropositivity.
- gen-003: # DIFFERENTIAL DIAGNOSIS ANALYSIS

## PRIMARY DIAGNOSIS: Early Rheumatoid Arthritis (Seronegative RA)
**Confidence: High**

**Supporting findings:**
- Symmetric polyarticular involvement of small joints (MCPs, PIPs, wrists) with typical distribution for RA
- Morning stiffness lasting 45 minutes with improvement on activity—classic for inflammatory arthropathy
- Elevated acute phase reactants (ESR 34, CRP 8.2) indicating active systemic inflammation
- Progressive, insidious onset with functional impairment (inability to make tight fists, pain with gripping)

**Findings against:**
- Negative RF and anti-CCP antibodies (seronegative presentation occurs in ~30% of RA cases, particularly early disease)
- Absence of erosions on imaging (expected in early disease; erosions typically develop within first 1-2 years)

---

## DIFFERENTIAL DIAGNOSIS:

1. **Early Seronegative Rheumatoid Arthritis (45%)** — for: symmetric MCP/PIP/wrist involvement, morning stiffness >30 min, elevated ESR/CRP, functional impairment | against: negative RF and anti-CCP at presentation

2. **Systemic Lupus Erythematosus (SLE) with arthralgias (25%)** — for: female of childbearing age, symmetric small joint involvement, elevated ESR | against: negative ANA (highly sensitive in SLE), absence of constitutional symptoms, no rash/photosensitivity, normal CBC

3. **Acute Viral Arthritis (polyomavirus, parvovirus B19) (15%)** — for: acute insidious onset, symmetric distribution, mild systemic inflammation | against: 3-week duration with progressive worsening (viral typically self-limited), no preceding URI or systemic prodrome

4. **Early Psoriatic Arthritis (10%)** — for: asymmetric presentation initially (right worse than left), small joint involvement | against: no skin lesions, no nail changes, no dactylitis appreciated, typical psoriatic pattern would show asymmetry more prominently

5. **Occupational Strain/Repetitive Stress Injury (5%)** — for: work as nurse, symptoms with gripping | against: symmetric bilateral distribution uncommon, elevated inflammatory markers, morning stiffness pattern inconsistent with mechanical injury

---

## REASONING:

The clinical presentation is highly suggestive of **inflammatory arthropathy** based on three key discriminators: (1) symmetric polyarticular involvement of MCP, PIP, and wrist joints—the most common sites affected by RA; (2) prominent morning stiffness lasting 45 minutes with improvement on activity, which is pathognomonic for systemic inflammatory disease; and (3) elevated acute phase reactants (ESR 34, CRP 8.2) confirming active inflammation. The negative ANA effectively excludes SLE as a primary diagnosis, despite the demographic profile fitting that population.

The seronegative status (negative RF and anti-CCP) does not exclude RA; approximately 20–30% of RA patients present seronegative, especially in early disease stages (symptoms only 3 weeks old). Seronegative RA carries similar prognosis and erosive potential as seropositive disease when accompanied by inflammatory markers and appropriate clinical features. The progressive nature over 3 weeks and functional impairment (inability to grip or make fists) distinguish this from benign viral arthritis, which typically peaks within 1–2 weeks and then resolves.

The absence of erosions is expected at 3 weeks; erosive changes typically emerge over months to years. The lack of skin manifestations, dactylitis, or asymmetry makes psoriatic arthritis less likely than RA.

---

## NEXT STEP:

**Obtain anti-CCP and RF antibodies with repeat testing in 4–6 weeks**, along with **high-resolution ultrasound or MRI of the hands/wrists to assess for synovitis and early erosions** (more sensitive than plain radiography for detecting bone changes). Additionally, **consider initiating a trial of DMARDs (e.g., methotrexate) concurrent with clinical follow-up**, as early intervention within the 3–6 month "window of opportunity" significantly improves long-term outcomes in RA regardless of serostatus. A positive anti-CCP conversion or progression on imaging would strongly confirm
- gen-004: # DIFFERENTIAL DIAGNOSIS ANALYSIS

**PRIMARY DIAGNOSIS: Systemic Lupus Erythematosus (SLE)**

**Confidence: High**

**Supporting findings:**
1. **Classic malar rash with nasolabial fold sparing** — pathognomonic presentation occurring during documented photosensitivity, a major SLE criterion
2. **Symmetric polyarticular arthritis (hands, wrists, knees) with morning stiffness >60 minutes** — characteristic lupus arthritis pattern
3. **Multisystem involvement**: oral ulcers, photosensitivity, alopecia, constitutional symptoms (fever, fatigue, weight loss), and dyspnea on exertion — fulfills multiple SLE classification criteria simultaneously in appropriate temporal relationship

---

## DIFFERENTIAL DIAGNOSIS:

1. **Systemic Lupus Erythematosus (SLE)** (78%) 
   — for: Malar rash sparing nasolabial folds + photosensitivity + symmetric polyarthritis + oral ulcers + alopecia + constitutional symptoms + dyspnea | against: None identified

2. **Rheumatoid Arthritis** (12%) 
   — for: Symmetric polyarticular arthritis with morning stiffness >60 minutes + soft tissue joint swelling | against: Absence of erosions on exam; malar rash with nasolabial sparing is not characteristic; photosensitivity and oral ulcers unexplained; acute multisystem presentation atypical for RA onset

3. **Acute Rheumatic Fever** (5%) 
   — for: Polyarthritis + erythema (though described differently) + constitutional symptoms | against: Erythema marginatum classically has pale centers with irregular borders; nasolabial involvement atypical; photosensitivity not a feature; no documented carditis or recent streptococcal pharyngitis; age and demographics less typical

4. **Drug-Induced Lupus Erythematosus (DILE)** (3%) 
   — for: Could produce lupus-like syndrome | against: Patient denies medication changes; photosensitivity and malar rash less prominent in DILE; alopecia and oral ulcers less typical; no mention of procainamide, hydralazine, or minocycline exposure

5. **Seronegative Spondyloarthropathy/Reactive Arthritis** (2%) 
   — for: Polyarthritis with systemic symptoms | against: Symmetric small joint pattern atypical; no urethritis, conjunctivitis, or GI symptoms; photosensitive malar rash completely inconsistent; oral ulcers (if present in reactive arthritis) lack the painless nature seen in aphthous ulcers associated with spondyloarthropathies

---

## REASONING:

This 28-year-old woman presents with a constellation of findings that almost precisely tracks the 2019 EULAR/ACR SLE classification criteria. The **malar rash with documented nasolabial fold sparing during photosensitivity** is virtually pathognomonic for SLE; this combination is rarely seen in other rheumatic diseases. The **symmetric polyarticular arthritis involving small joints (hands, wrists) and knees with prolonged morning stiffness** is characteristic of lupus arthritis, though RA remains in the differential until serologies clarify. However, the **multisystem presentation within a short 6-week window**—including photosensitivity, oral ulcers, alopecia, constitutional symptoms, and dyspnea—strongly favors SLE over monoarticular diagnoses. The temporal clustering of cutaneous, articular, and systemic manifestations, combined with the patient's demographic (young woman of reproductive age), makes RA less likely as a primary diagnosis despite overlapping arthritis features. Rheumatic fever would typically present with more acute carditis and different rash characteristics. The absence of any recent medication exposure and the prominence of photosentivity-triggered manifestations essentially exclude DILE.

---

## NEXT STEP:

**Antinuclear Antibody (ANA) panel with reflex to specific autoantibodies (anti-dsDNA and anti-Smith antibodies)**

**Expected findings to confirm SLE:**
- **ANA: Positive** (≥1:160 titer, ideally with diffuse/homogeneous or speck
- gen-005: # DIFFERENTIAL DIAGNOSIS ANALYSIS

## PRIMARY DIAGNOSIS: Systemic Lupus Erythematosus (SLE)
**Confidence: High**

**Supporting findings:**
- Classic malar rash (photosensitive, symmetric across cheeks and nasal bridge) with constitutional symptoms (fever, fatigue, weight loss)
- Migratory polyarthralgia without joint swelling—typical of SLE arthritis, which is non-erosive and often seronegative
- Recurrent pregnancy loss (12 and 16 weeks) suggesting antiphospholipid syndrome (APS) association with SLE
- Cytopenias: leukopenia (3,200/μL) with normocytic anemia (10.8 g/dL) and mild thrombocytopenia (156,000/μL)
- Markedly elevated ESR (48 mm/hr) with modest CRP elevation—characteristic SLE inflammatory pattern

**Findings against:**
- Absence of oral ulcers and other photosensitive skin lesions (though not required for SLE diagnosis)
- None identified as truly contradictory; seronegative SLE remains consistent with this presentation

---

## DIFFERENTIAL DIAGNOSIS:

1. **Antiphospholipid Syndrome (APS) - primary or SLE-associated** (25%) — 
   *for:* Recurrent second-trimester miscarriages (thrombotic/obstetric complications) | 
   *against:* No clinical thrombosis, malar rash more suggestive of concurrent SLE

2. **Acute Rheumatic Fever (ARF)** (12%) — 
   *for:* Migratory polyarthralgia, fever, elevated inflammatory markers | 
   *against:* No documented antecedent streptococcal infection, malar rash atypical for ARF, absence of carditis findings on exam

3. **Lyme Arthritis** (8%) — 
   *for:* Migratory arthralgia pattern, recurrent nature | 
   *against:* No travel/endemic exposure history, does not explain malar rash, fever pattern, cytopenias, or pregnancy losses

4. **Rheumatoid Arthritis (seronegative)** (5%) — 
   *for:* Polyarticular involvement (wrists, knees, ankles) | 
   *against:* Lack of joint swelling on exam, migratory pattern unusual for RA, malar rash not typical, no morning stiffness

5. **Adult-onset Still's Disease** (3%) — 
   *for:* Fever, arthralgia, weight loss | 
   *against:* No quotidian fever pattern, no salmon-colored rash, absent lymphadenopathy/hepatosplenomegaly

---

## REASONING:

This clinical presentation is highly suggestive of SLE based on a convergence of pathognomonic features. The malar rash with photosensitivity is a hallmark sign, occurring in ~40% of SLE patients and essentially never seen in seronegative RA. The pattern of *migratory* polyarthralgia without objective joint swelling is characteristic of SLE arthritis, which is typically non-erosive, non-destructive, and seronegative—contrasting sharply with RA's symmetrical, persistent, swollen joint pattern. The constellation of cytopenias (leukopenia, normocytic anemia, mild thrombocytopenia) represents lupus-associated hematologic involvement. Critically, the recurrent second-trimester pregnancy losses in a young woman without obstetric explanation suggest either APS alone or APS comorbid with SLE, both of which fit this case. The disproportionately elevated ESR relative to CRP is classic for SLE (immune complex-mediated) compared to bacterial/viral processes. The 14-month disease trajectory with constitutional symptoms and progressive manifestations further supports SLE over ARF (which follows acute strep) or Lyme disease (which would require epidemiologic exposure).

---

## NEXT STEP:

**Antinuclear Antibody (ANA) testing by HEp-2 immunofluorescence**

*Expected finding:* A positive ANA (>1:80 titer) is present in >95% of SLE patients and is essential for diagnosis. Additionally, obtain **
